Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune liver diseases.

I G McFarlane1

  • 1Institute of Liver Studies, King's College Hospital, London, UK. ((())). ian.mcfarlane@kcl.ac.uk

Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum
|November 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoantibodies in alcoholic liver disease.

Addiction biology·2010
Same author

Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.

Alimentary pharmacology & therapeutics·2008
Same author

Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin.

Gut·2002
Same author

Autoimmune hepatitis: Clinical manifestations and diagnostic criteria.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie·2001
Same author

Management and outcome of pregnancy in autoimmune hepatitis.

Gut·2000
Same author

HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland.

Liver·2000
Same journal

Standardization of tumor markers - priorities identified through external quality assessment.

Scandinavian journal of clinical and laboratory investigation. Supplementum·2016
Same journal

Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.

Scandinavian journal of clinical and laboratory investigation. Supplementum·2016
Same journal

microRNAs as cancer biomarkers.

Scandinavian journal of clinical and laboratory investigation. Supplementum·2016
Same journal

Biomarkers along the continuum of care in lung cancer.

Scandinavian journal of clinical and laboratory investigation. Supplementum·2016
Same journal

Precision medicine: what's all the fuss about?

Scandinavian journal of clinical and laboratory investigation. Supplementum·2016
Same journal

Serum thyroglobulin in the monitoring of differentiated thyroid cancer.

Scandinavian journal of clinical and laboratory investigation. Supplementum·2016
See all related articles

Diagnosing autoimmune liver diseases like autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC) requires excluding other conditions and analyzing specific autoantibodies. New liver-specific autoantibodies show promise for more accurate AIH diagnosis.

Area of Science:

  • Hepatology
  • Immunology
  • Autoimmune Diseases

Background:

  • Autoimmune liver diseases (AIH, PBC, PSC) diagnosis relies on excluding other chronic liver conditions and identifying specific serological markers.
  • Conventional autoantibodies and biochemical parameters show variability and limited specificity in differentiating these diseases.
  • Current diagnostic methods often necessitate liver histology or cholangiography for definitive diagnosis and staging.

Purpose of the Study:

  • To review the diagnostic challenges and current serological markers for autoimmune liver diseases.
  • To highlight the diagnostic utility and limitations of conventional autoantibodies.
  • To introduce promising novel autoantibodies for improved diagnosis of autoimmune hepatitis (AIH).

Main Methods:

Related Experiment Videos

  • Review of existing literature on the diagnosis of autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC).
  • Analysis of the specificity and sensitivity of various autoantibodies, including antimitochondrial antibodies (AMA) and anti-liver-kidney microsomal (anti-LKM) antibodies.
  • Discussion of the role of liver biopsy and cholangiography in differential diagnosis.

    • Main Results:

    • Antimitochondrial antibodies (AMA) are highly specific for PBC, while anti-LKM antibodies are specific for a subset of AIH (type 2).
    • Most conventional autoantibodies lack specificity for differentiating between AIH, PBC, and PSC.
    • Significant variability exists within and between these disease groups, complicating diagnosis.
    • Novel autoantibodies targeting liver-specific antigens show potential for more precise AIH diagnosis.

    Conclusions:

    • Accurate diagnosis of autoimmune liver diseases remains challenging, often requiring a combination of clinical, biochemical, immunological, and histological data.
    • While conventional autoantibodies have diagnostic roles, their limitations necessitate further investigation.
    • Emerging liver-specific autoantibodies offer hope for more accurate and earlier diagnosis, particularly for AIH.